# AGIOS PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/agios-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 28 | | Claims under review | 1 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:45:58.418703+00:00 | | Last reviewed | 2026-10-17T04:45:58.418703+00:00 | ## Identity - Legal name: AGIOS PHARMACEUTICALS, INC. - Display name: AGIOS PHARMACEUTICALS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T05:24:03.430839+00:00 | | Completeness | 0.409 | | Record Quality | 0.847 | | Directors | 9 | | Committees | 4 | | Governance events | 18 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Brian Goff: Director. Status: current. Independent: false. Since: 2022-01-01. claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:5 - Catherine Owen: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:6 - Cynthia Smith: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:7 - David Scadden, M.D.: Director. Status: current. Independent: true. Since: 2017-01-01. claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:8 - Jacqualyn A. Fouse, Ph.D.: Director. Status: current. Independent: false. Since: 2017-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:9 - Jeffrey Capello: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member). claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:10 - Kaye Foster: Director. Status: current. Independent: true. Since: 2014-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:11 - Maykin Ho: Director. Status: current. Independent: true. Since: 2015-01-01. Committees: Audit (member). claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:12 - Rahul Ballal, Ph.D.: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:13 ## Committees - Audit (audit). Chair: NOT_PUBLISHED. Members: Jacqualyn A. Fouse, Ph.D. (member, current); Jeffrey Capello (member, current); Maykin Ho (member, current). committee_id=alpha:committee:agios-pharmaceuticals-inc:audit - Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Jacqualyn A. Fouse, Ph.D. (member, current). committee_id=alpha:committee:agios-pharmaceuticals-inc:audit-nominating-and-governance - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Catherine Owen (member, current); Kaye Foster (member, current). committee_id=alpha:committee:agios-pharmaceuticals-inc:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Jacqualyn A. Fouse, Ph.D. (member, current). committee_id=alpha:committee:agios-pharmaceuticals-inc:nominating-and-governance ## Executive leadership - Brian Goff: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:14 - Cecilia Jones: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:15 - James Burns: Chief Legal Officer [GC]. Status: current. claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:16 - Krishnan Viswanadhan: Chief Corporate Development Strategy Officer. Status: current. claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:17 - Sarah Gheuens: Chief Medical Officer, Head of Research Development. Status: current. claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:18 - Tsveta Milanova: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:19 ## Governance events - CEO_CHANGED: Brian Goff executive of AGIOS PHARMACEUTICALS, INC., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:dmazee1i7kxyc - CFO_CHANGED: Cecilia Jones executive of AGIOS PHARMACEUTICALS, INC., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:equbd5bmgibh - GC_CHANGED: James Burns executive of AGIOS PHARMACEUTICALS, INC., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:d25rf719csl21 - EXECUTIVE_APPOINTED: Krishnan Viswanadhan executive of AGIOS PHARMACEUTICALS, INC., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:1ssecj5fb42td - EXECUTIVE_APPOINTED: Sarah Gheuens executive of AGIOS PHARMACEUTICALS, INC., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:uxn96px94r5h - EXECUTIVE_APPOINTED: Tsveta Milanova executive of AGIOS PHARMACEUTICALS, INC., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:5pmlu91rcnkgt - DIRECTOR_APPOINTED: Catherine Owen seat on AGIOS PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:188yalq3vqjfw - DIRECTOR_APPOINTED: Jeffrey Capello seat on AGIOS PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:1j8vf9tdw4ikr - COMMITTEE_MEMBER_ADDED: Catherine Owen member of Compensation, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:1ognpr21gidhd6 - DIRECTOR_APPOINTED: Brian Goff seat on AGIOS PHARMACEUTICALS, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:x4pddq9mmaci - DIRECTOR_APPOINTED: Cynthia Smith seat on AGIOS PHARMACEUTICALS, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:g36gv61l2895o - DIRECTOR_APPOINTED: Rahul Ballal, Ph.D. seat on AGIOS PHARMACEUTICALS, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:cla5y1erhbrh - DIRECTOR_APPOINTED: David Scadden, M.D. seat on AGIOS PHARMACEUTICALS, INC., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:8od9iz16iziv9 - DIRECTOR_APPOINTED: Jacqualyn A. Fouse, Ph.D. seat on AGIOS PHARMACEUTICALS, INC., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:o2zhz41x2mbmg - COMMITTEE_CREATED: Audit; Nominating and Governance committee of AGIOS PHARMACEUTICALS, INC., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:10z27h2n9v2t0 - COMMITTEE_MEMBER_ADDED: Jacqualyn A. Fouse, Ph.D. member of Audit; Nominating and Governance, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:156tgie165uca6 - DIRECTOR_APPOINTED: Maykin Ho seat on AGIOS PHARMACEUTICALS, INC., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:13ng7o8vsd5zs - DIRECTOR_APPOINTED: Kaye Foster seat on AGIOS PHARMACEUTICALS, INC., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:2et9lcs3pm0m ## Scoped resources - `alpha://company/agios-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record - `alpha://company/agios-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/agios-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/agios-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=board - `alpha://company/agios-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/agios-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/agios-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/agios-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/agios-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/agios-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/agios-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/agios-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/agios-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/agios-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/agios-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/agios-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/agios-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/agios-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/agios-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/agios-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=events - `alpha://company/agios-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/agios-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/agios-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jacqualyn-a-fouse-phd","name":"Jacqualyn A. Fouse, Ph.D."},"source_id":"board_seats"}` - Claim alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jeffrey-capello","name":"Jeffrey Capello"},"source_id":"board_seats"}` - Claim alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:maykin-ho","name":"Maykin Ho"},"source_id":"board_seats"}` - Claim alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:catherine-owen","name":"Catherine Owen"},"source_id":"board_seats"}` - Claim alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:kaye-foster","name":"Kaye Foster"},"source_id":"board_seats"}` - Claim alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jacqualyn-a-fouse-phd","name":"Jacqualyn A. Fouse, Ph.D."},"source_id":"board_seats"}` ## Leadership - Brian Goff: Director. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:5. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c2b7df3c489fe8ccb13c9d1bdc1b217bbc1963de3a3b09d4b6f3bd6168093cf. - Catherine Owen: Director, Compensation. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c2b7df3c489fe8ccb13c9d1bdc1b217bbc1963de3a3b09d4b6f3bd6168093cf. - Cynthia Smith: Director. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c2b7df3c489fe8ccb13c9d1bdc1b217bbc1963de3a3b09d4b6f3bd6168093cf. - David Scadden, M.D.: Director. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:8. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c2b7df3c489fe8ccb13c9d1bdc1b217bbc1963de3a3b09d4b6f3bd6168093cf. - Jacqualyn A. Fouse, Ph.D.: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:9. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c2b7df3c489fe8ccb13c9d1bdc1b217bbc1963de3a3b09d4b6f3bd6168093cf. - Jeffrey Capello: Director, Audit. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:10. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c2b7df3c489fe8ccb13c9d1bdc1b217bbc1963de3a3b09d4b6f3bd6168093cf. - Kaye Foster: Director, Compensation. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:11. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c2b7df3c489fe8ccb13c9d1bdc1b217bbc1963de3a3b09d4b6f3bd6168093cf. - Maykin Ho: Director, Audit. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:12. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c2b7df3c489fe8ccb13c9d1bdc1b217bbc1963de3a3b09d4b6f3bd6168093cf. - Rahul Ballal, Ph.D.: Director. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:13. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c2b7df3c489fe8ccb13c9d1bdc1b217bbc1963de3a3b09d4b6f3bd6168093cf. - Brian Goff: Chief Executive Officer. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:14. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fa7a962caeafbd801aebcff84b5f171bfe88c3c9e1a92f054c1c0d0997c38522. - Cecilia Jones: Chief Financial Officer. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:15. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:363def1ba247b615054b7864b34f35fd89c9940dbd1da341838a6364e7be3d34. - James Burns: Chief Legal Officer. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:16. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:16c264d20580ae3a71da18597e270138badffe111a039d20d107f3f26df043ca. - Krishnan Viswanadhan: Chief Corporate Development Strategy Officer. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:17. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:806f945bbfddef0c02931cba9fccfc5eb29aaa3c5a79614e07422196d93714f5. - Sarah Gheuens: Chief Medical Officer, Head of Research Development. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:18. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0b83b15e9169bd9c9864f91b4d75aaf0db9a1461ad297d56735d7a0f9ade35fd. - Tsveta Milanova: Chief Commercial Officer. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:leadership_role:19. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3c6374139f64aae290d270aa451f3da37939c609d4c85d18336b86769b9703df. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair not stated; Members Jacqualyn A. Fouse, Ph.D.; Jeffrey Capello; Maykin Ho. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:349feaafa56c296ebf6b934eb4adf6ba16ae6176f83e79582c977b4e75f62486. - Compensation: Chair not stated; Members Catherine Owen; Kaye Foster. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:349feaafa56c296ebf6b934eb4adf6ba16ae6176f83e79582c977b4e75f62486. - Nominating and Governance: Chair not stated; Members Jacqualyn A. Fouse, Ph.D.. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_record:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:349feaafa56c296ebf6b934eb4adf6ba16ae6176f83e79582c977b4e75f62486. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - AGIOS PHARMACEUTICALS, INC.. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a6e3725e8c6d4150b3d8370b0b36e8c51b8091c143af5b147490fc590e311fa1. ## Entity Status - Public listing published. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a6e3725e8c6d4150b3d8370b0b36e8c51b8091c143af5b147490fc590e311fa1. ## Published Fact - US. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a6e3725e8c6d4150b3d8370b0b36e8c51b8091c143af5b147490fc590e311fa1. ## Committee Appointment - Jacqualyn A. Fouse, Ph.D.: member, Audit. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:349feaafa56c296ebf6b934eb4adf6ba16ae6176f83e79582c977b4e75f62486. - Jeffrey Capello: member, Audit. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:349feaafa56c296ebf6b934eb4adf6ba16ae6176f83e79582c977b4e75f62486. - Maykin Ho: member, Audit. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:349feaafa56c296ebf6b934eb4adf6ba16ae6176f83e79582c977b4e75f62486. - Catherine Owen: member, Compensation. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:349feaafa56c296ebf6b934eb4adf6ba16ae6176f83e79582c977b4e75f62486. - Kaye Foster: member, Compensation. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:349feaafa56c296ebf6b934eb4adf6ba16ae6176f83e79582c977b4e75f62486. - Jacqualyn A. Fouse, Ph.D.: member, Nominating and Governance. Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:349feaafa56c296ebf6b934eb4adf6ba16ae6176f83e79582c977b4e75f62486. ## Security Listing - AGIO (NASDAQ). Claim: alpha:claim:company:8eb0517b-89ff-48ea-8bd2-d86921ac7aa0:security_listing:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a6e3725e8c6d4150b3d8370b0b36e8c51b8091c143af5b147490fc590e311fa1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:a6e3725e8c6d4150b3d8370b0b36e8c51b8091c143af5b147490fc590e311fa1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/agios-pharmaceuticals-inc). - alpha:projection-evidence:document:4c2b7df3c489fe8ccb13c9d1bdc1b217bbc1963de3a3b09d4b6f3bd6168093cf: [AGIOS PHARMACEUTICALS, INC. DEF 14A 2025-04-25](https://www.sec.gov/Archives/edgar/data/1439222/000119312525096719/d838751ddef14a.htm). - alpha:projection-evidence:document:fa7a962caeafbd801aebcff84b5f171bfe88c3c9e1a92f054c1c0d0997c38522: [AGIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1439222/000119312526177086/d943609ddef14a.htm). - alpha:projection-evidence:document:363def1ba247b615054b7864b34f35fd89c9940dbd1da341838a6364e7be3d34: [AGIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1439222/000119312526177086/d943609ddef14a.htm). - alpha:projection-evidence:document:16c264d20580ae3a71da18597e270138badffe111a039d20d107f3f26df043ca: [AGIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1439222/000119312526177086/d943609ddef14a.htm). - alpha:projection-evidence:document:806f945bbfddef0c02931cba9fccfc5eb29aaa3c5a79614e07422196d93714f5: [AGIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1439222/000119312526177086/d943609ddef14a.htm). - alpha:projection-evidence:document:0b83b15e9169bd9c9864f91b4d75aaf0db9a1461ad297d56735d7a0f9ade35fd: [AGIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1439222/000119312526177086/d943609ddef14a.htm). - alpha:projection-evidence:document:3c6374139f64aae290d270aa451f3da37939c609d4c85d18336b86769b9703df: [AGIO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1439222/000119312526177086/d943609ddef14a.htm). - alpha:projection-evidence:349feaafa56c296ebf6b934eb4adf6ba16ae6176f83e79582c977b4e75f62486: [Audit](https://www.sec.gov/Archives/edgar/data/1439222/000119312525096719/d838751ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/agios-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/agios-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/agios-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/agios-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T05:24:03.213995+00:00; recorded 2026-10-17T05:24:03.213995+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.